Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators

被引:8
|
作者
Salum, L. B. [1 ]
Polikarpov, I. [1 ]
Andricopulo, A. D. [1 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecn Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
estrogen receptor; hormone replacement therapy; ER beta binding affinity; HQSAR;
D O I
10.1080/10629360701698811
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The estrogen receptor-beta subtype (ERP) is an attractive drug target for the development of novel therapeutic agents for hormone replacement therapy. Hologram quantitative structure-activity relationships (HQSAR) were conducted on a series of 6-phenylnaphthalene and 2-phenylquinoline derivatives, employing values of ER binding affinity. A training set of 65 compounds served to derive the models. The best statistical HQSAR model (q(2) =0.73 and r(2) = 0.9 1) was generated using atoms, bonds, connections and donor and acceptor as fragment distinction parameters, and fragment size default (4-7) with hologram length of 199. The model was used to predict the binding affinity of an external test set of 16 compounds, and the predicted values were in good agreement with the experimental results. The Final HQSAR model and the information obtained from 2D contribution maps should be useful for the design of novel ERP modulators having improved affinity.
引用
收藏
页码:711 / 727
页数:17
相关论文
共 50 条
  • [41] Selective estrogen receptor modulators
    Ansbacher, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (04) : 1036 - 1036
  • [42] Selective estrogen receptor modulators
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (05) : 217 - 217
  • [43] Selective estrogen receptor modulators
    Nicole M. Petersen
    Amber L. Briggs
    Clinical Reviews in Bone and Mineral Metabolism, 2005, 3 (1): : 19 - 30
  • [44] Structure-Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists
    Sedlak, David
    Wilson, Tyler A.
    Tjarks, Werner
    Radomska, Hanna S.
    Wang, Hongyan
    Kolla, Jayaprakash Narayana
    Lesnikowski, Zbigniew J.
    Spicakova, Alena
    Ali, Tehane
    Ishita, Keisuke
    Rakotondraibe, Liva Harinantenaina
    Vibhute, Sandip
    Wang, Dasheng
    Anzenbacher, Pavel
    Bennett, Chad
    Bartunek, Petr
    Coss, Christopher C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 9330 - 9353
  • [45] Selective estrogen receptor-beta agonists are potent anti inflammatory agents.
    Magolda, RL
    Malamas, MS
    Mewshaw, RE
    Harris, HA
    Keith, JC
    McDevitt, B
    Gunawan, I
    Miller, CP
    Albert, LM
    Leathurby, Y
    Manas, ES
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U942 - U942
  • [46] A novel selective estrogen receptor-beta agonist for the treatment of menopausal hot flushes
    Grady, D.
    Sawaya, G. F.
    Johnson, K. C.
    Koltun, W.
    Hess, R.
    Vittinghoff, E.
    Kristof, M.
    Tagliaferri, M.
    Cohen, I.
    Ensrud, K. E.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1081 - 1081
  • [47] Structure-Activity Relationship Study of Tris-Benzamides as Estrogen Receptor Coregulator Binding Modulators
    Lee, Tae-Kyung
    Kassees, Kara
    Chen, Chia-Yuan
    Viswanadhapalli, Suryavathi
    Parra, Karla
    Vadlamudi, Ratna K.
    Ahn, Jung-Mo
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, : 2023 - 2043
  • [48] Molecular modeling reveals binding features of estrogen receptor-beta selective ligands
    Ksiazek, P.
    Kaczor, A.
    Bryl, K.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S169 - S169
  • [49] Estrogen receptor-beta: A new form of estrogen receptor in breast cancer
    Cullen, R
    Maguire, TM
    McDermott, E
    O'Higgins, N
    Duffy, MJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
  • [50] Synthesis, Structure-Activity Relationships and Antagonistic Effects in Human MCF-7 Breast Cancer Cells of Flexible Estrogen Receptor Modulators
    Lloyd, David G.
    Smith, Helena M.
    O'Sullivan, Timothy
    Zisterer, Daniela M.
    Meegan, Mary J.
    MEDICINAL CHEMISTRY, 2005, 1 (04) : 335 - 353